IQVIA™ Real-World Insights Bibliography
High?Expenditure Disease in the EU?28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes? |
Author(s): Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck |
Affiliations(s): Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium |
Publication(s): PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4
|
Document Type(s): Article, |
Countries: Europe, |
Click here for the abstract |
C: Y: |
Diabetes, Health economics, Oncology, 2021 |
|
L: A: |
English Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review, |
|
|
|
|
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study |
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 |
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain |
Publication(s): IPVC, Barcelona, Spain, 23-27 March 2020
|
Document Type(s): Oral presentation, |
Countries: China, France, Germany, Italy, Japan, Portugal, Spain, |
C: Y: |
Infectious disease, Oncology, 2020 |
|
L: A: |
English Burden of illness, Observational study, Retrospective Field Study, |
|
|
|
|
Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France |
Author(s): Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4 |
Affiliations(s): 1 Sorbonne Université, medical oncology department, AP-HP, hôpital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France |
Publication(s): ESMO GI, Barcelona, Spain 1-4 July 2020
|
Document Type(s): Poster, |
Countries: France, |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Observational study, Population Based Study, Retrospective Field Study, |
|
|
|
|
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer |
Author(s): Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7 |
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy |
Publication(s): BMC Gastroenterology BMC Gastroenterology volume 20, Article number: 133 (2020)
|
Document Type(s): Article, |
Countries: Australia, Canada, Italy, UK, |
Click here for the abstract |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Retrospective cohort analysis, |
|
|
|
|
Nivolumab-treated non-small cell lung cancer patients in the United Kingdom |
Author(s): Carroll R1, Tanna N1, Ghosh S2, Sanchez E3, Stawiarska Z4, Gemmen E5 |
Affiliations(s): 1 Bristol-Myers Squibb, Uxbridge, UK 2 IQVIA, Gurugram, India 3 IQVIA, Barcelona, Spain 4 IQVIA, Warsaw, Poland 5 IQVIA, Rockville, MD, US |
Publication(s): BMC Gastroenterology
|
Document Type(s): Article, |
Countries: UK, |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Observational study, Population Based Study, Retrospective Field Study, |
|
|
|
|
Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach |
Author(s): Guilherme Silva Julian 1,
Ricardo Papaléo Rosim 2,
Estela Cristina Carneseca 3,
Jéssica Rigolon 2 |
Affiliations(s): 1 IQVIA Brasil, São Paulo-SP, Brazil.
2 Biogen Brasil, São Paulo-SP, Brazil.
3 Proestat Consultoria Estatística, Ribeirão Preto-SP, Brazil. |
Publication(s): PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768
|
Document Type(s): Article, |
Countries: Brazil, |
Click here for the abstract |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Retrospective database analysis, |
|
|
|
|
Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan |
Author(s): Iguch.T1, Nakamura.Y2, Akiyama.T3, Krishant C3, Yu E3 |
Affiliations(s):
1 Osaka City University Graduate School of Medicine Urology and Pathology, 2 Bayer Yakuhin Co., Ltd. Market Access Headquarters, 3 IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions |
Publication(s): Accepted Presentation Japanese Urological Association 2020
|
Document Type(s): Abstract, |
Countries: Japan, |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Survey research, |
|
|
|
|
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study |
Author(s): Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D?Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5 |
Affiliations(s): 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy |
Publication(s): COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
|
Document Type(s): Poster, |
Countries: Canada, Italy, UK, |
C: Y: |
Hematology, Oncology, 2020 |
|
L: A: |
English Population Based Study, |
|
|
|
|
Modernizing Regulatory Evidence with Trials and Real-World Studies
|
Author(s): Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE |
Affiliations(s): IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA
Nancy A. Dreyer PhD, MPH, FISPE
IQVIA Real-World Solutions, Rockville, MD, USA
Marni Hall PhD, MPH
IQVIA Real World Solutions, Research Triangle Park, NC, USA
Jennifer B. Christian PharmD, MPH, PhD, FISPE |
Publication(s): Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5
|
Document Type(s): Article, |
Countries: USA, |
Click here for the abstract |
C: Y: |
Oncology, 2020 |
|
L: A: |
English Retrospective database analysis, |
|
|
|
|
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC) |
Author(s): Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6 |
Affiliations(s): 1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy |
Publication(s): BMC Gastroenterology volume 20, Article number: 133 (2020)
|
Document Type(s): Poster, |
Countries: Australia, Canada, Italy, UK, |
C: Y: |
Oncology, 2019 |
|
L: A: |
English Retrospective cohort analysis, |
|
|
|
|
1 of 58
|
|